Zota Health Care LImited (ZOTA) - Total Assets
Based on the latest financial reports, Zota Health Care LImited (ZOTA) holds total assets worth Rs6.06 Billion INR (≈ $65.53 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore ZOTA operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Zota Health Care LImited - Total Assets Trend (2012–2025)
This chart illustrates how Zota Health Care LImited's total assets have evolved over time, based on quarterly financial data. See ZOTA net assets for net asset value and shareholders' equity analysis.
Zota Health Care LImited - Asset Composition Analysis
Current Asset Composition (March 2025)
Zota Health Care LImited's total assets of Rs6.06 Billion consist of 41.9% current assets and 58.1% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs14.87 Million | 0.5% |
| Accounts Receivable | Rs574.92 Million | 13.1% |
| Inventory | Rs1.06 Billion | 24.1% |
| Property, Plant & Equipment | Rs1.87 Billion | 42.6% |
| Intangible Assets | Rs49.16 Million | 1.1% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Zota Health Care LImited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ZOTA market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zota Health Care LImited's current assets represent 41.9% of total assets in 2025, a decrease from 64.8% in 2012.
- Cash Position: Cash and equivalents constituted 0.5% of total assets in 2025, up from 0.4% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2012.
- Asset Diversification: The largest asset category is property, plant & equipment at 42.6% of total assets.
Zota Health Care LImited Competitors by Total Assets
Key competitors of Zota Health Care LImited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
Verona Pharma plc
F:I9SA
|
Germany | €572.87 Million |
|
Xiamen Amoytop Biotech Co Ltd
SHG:688278
|
China | CN¥3.21 Billion |
|
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
|
USA | $472.67 Million |
|
Neuren Pharmaceuticals Ltd
AU:NEU
|
Australia | AU$331.25 Million |
|
Vor Biopharma Inc
NASDAQ:VOR
|
USA | $506.75 Million |
|
Chengdu Kanghua Biological Products
SHE:300841
|
China | CN¥3.94 Billion |
|
Jiangsu Aidea Pharmaceutical Co Ltd
SHG:688488
|
China | CN¥1.84 Billion |
Zota Health Care LImited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.70 | 1.74 | 2.68 |
| Quick Ratio | 0.88 | 0.84 | 1.36 |
| Cash Ratio | 0.00 | 0.01 | 0.00 |
| Working Capital | Rs1.00 Billion | Rs529.41 Million | Rs450.50 Million |
Zota Health Care LImited - Advanced Valuation Insights
This section examines the relationship between Zota Health Care LImited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 15.65 |
| Latest Market Cap to Assets Ratio | 0.09 |
| Asset Growth Rate (YoY) | 92.3% |
| Total Assets | Rs4.39 Billion |
| Market Capitalization | $415.20 Million USD |
Valuation Analysis
Below Book Valuation: The market values Zota Health Care LImited's assets below their book value (0.09x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Zota Health Care LImited's assets grew by 92.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Zota Health Care LImited (2012–2025)
The table below shows the annual total assets of Zota Health Care LImited from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | Rs4.39 Billion ≈ $47.49 Million |
+92.33% |
| 2024-03-31 | Rs2.28 Billion ≈ $24.69 Million |
+44.41% |
| 2023-03-31 | Rs1.58 Billion ≈ $17.10 Million |
+13.67% |
| 2022-03-31 | Rs1.39 Billion ≈ $15.04 Million |
+62.74% |
| 2021-03-31 | Rs854.69 Million ≈ $9.24 Million |
-3.40% |
| 2020-03-31 | Rs884.79 Million ≈ $9.57 Million |
-1.26% |
| 2019-03-31 | Rs896.07 Million ≈ $9.69 Million |
-2.38% |
| 2018-03-31 | Rs917.94 Million ≈ $9.93 Million |
+70.61% |
| 2017-03-31 | Rs538.05 Million ≈ $5.82 Million |
+22.14% |
| 2016-03-31 | Rs440.52 Million ≈ $4.76 Million |
+14.81% |
| 2015-03-31 | Rs383.68 Million ≈ $4.15 Million |
+15.65% |
| 2014-03-31 | Rs331.75 Million ≈ $3.59 Million |
+12.90% |
| 2013-03-31 | Rs293.85 Million ≈ $3.18 Million |
+3.18% |
| 2012-03-31 | Rs284.79 Million ≈ $3.08 Million |
-- |
About Zota Health Care LImited
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores u… Read more